Metal Compounds in Cancer Therapy

Buch | Hardcover

304 Seiten

1994 | and ed.
Chapman and Hall (Verlag)
978-0-412-54280-0 (ISBN)

Artikel merken

The discovery of the anti-tumour activity of cisplatin in 1965, and its subsequent introduction into clinical trials in 1971, was the catalyst for a major research effort into the potential of metal compounds in cancer therapy. This book provides a discussion of metal compounds in cancer therapy. This book should be of interest to research workers in the pharmaceutical industry, particularly tumour pharmacologists, tumour biologists, medicinal chemists and oncologists.

Introduction, S.P. Fricker. Platinum Anti-Cancer Drugs L.R. Kelland. Gold, F. Shaw III. Ruthenium Compound in Cancer Therapy, G. Sava. Rhodium, Iridium and Palladium Compounds as Experimental Anticancer Drugs, G. Buckley. Organometallic Titanium, Vanadium, Niobium, Molybdenum and Rhenium Complexes - Early Transition Metal Anti-Tumour Drugs, P. Kopf-Maier and H. Kopf. Anti-tumour Activity of Tin Compounds, A.J. Crowe. Gallium Compounds in Cancer Therapy, P. Collery. Bleomycin and Metal Interactions, J.M.C. Gutteridge. The In Vivo use of Metallic Radioisotopes in Cancer Detection and Imaging, D.J. Hnatowich.

Reihe/Serie	Metals in Health & Disease S. ; v. 1
Zusatzinfo	93 line illustrations, 2 halftones, index
Verlagsort	London
Sprache	englisch
Maße	156 x 234 mm
Gewicht	480 g
Einbandart	gebunden
Themenwelt	Medizin / Pharmazie ► Medizinische Fachgebiete ► Onkologie
	Medizin / Pharmazie ► Medizinische Fachgebiete ► Pharmakologie / Pharmakotherapie
	Medizin / Pharmazie ► Pharmazie
ISBN-10	0-412-54280-3 / 0412542803
ISBN-13	978-0-412-54280-0 / 9780412542800
Zustand	Neuware